講演・口頭発表等 - 末永　光邦

41. Shusuke Yagi, Eiji Shinozaki, Keisho Chin, Mitsukuni Suenaga, Daisuke Takahari, Mariko Ogura, Takashi Ichimura, Takeru Wakatsuki, Masato Ozaka, Izuma Nakayama, TOMOHIRO MATSUSHIMA, Hiroki Osumi, Kensei Yamaguch. Clinical impact of diverting ileostomy on the dose intensity of adjuvant chemotherapy for colorectal cancer.. ASCO-GI 2018.01

42. Daisuke Takahari, Takeru Wakatsuki, Tetsuo Mashima, Keisho Chin, Takashi Ichimura, Mariko Ogura, TOMOHIRO MATSUSHIMA, Hiroki Osumi, Izuma Nakayama, Yumiko Ota, Eiji Shinozaki, Mitsukuni Suenaga, Naomi Kawata, Yuki Horiike, Hiroyuki Seimiya, Naoya Fujita, Kensei Yamaguchi. Plasma biomarker analysis of ramucirumab in Japanese patients with advanced gastric cancer.. ASCO-GI 2018.01

43. Yumiko Ota, Takeru Wakatsuki, Tetsuo Mashima, Daisuke Takahari, Keisho Chin, Takashi Ichimura, Mariko Ogura, TOMOHIRO MATSUSHIMA, Hiroki Osumi, Izuma Nakayama, Eiji Shinozaki, Mitsukuni Suenaga, Naomi Kawata, Yuki Horiike, Hiroyuki Seimiya, Naoya Fujita, Kensei Yamaguchi. Plasma biomarker dynamics following ramucirumab treatment and survival analysis after ramucirumab treatment failure in patients with advanced gastric cancer.. ASCO-GI 2018.01

44. Ryo Takahashi, Takeru Wakatsuki, Eiji Shinozaki, Senzo Taguchi, Yoshiya Fujimoto, Hiroki Osumi, Yumiko Ota, TOMOHIRO MATSUSHIMA, Mariko Ogura, Takashi Ichimura, Daisuke Takahari, Mitsukuni Suenaga, Keisho Chin, Masahiko Oguchi, Masashi Ueno, Kensei Yamaguchi. Chemoradiation for the treatment of locoregional squamous cell carcinoma of the anal canal: A single center retrospective analysis in Japan.. ASCO-GI 2018.01

45. Tomoyo Oguri, Daisuke Takahari, Yumiko Ota, Hiroki Osumi, Izuma Nakayama, Takeru Wakatsuki, Mariko Ogura, Takashi Ichimura, Mitsukuni Suenaga, Eiji Shinozaki, Keisho Chin, Kensei Yamaguchi. The clinical analysis of thromboembolism in esophagogastric cancer in Japan: A single institute experience.. ASCO-GI 2018.01

46. Nakayama Izuma, Chin Keisho, Matsushima Tomohiro, Takahari Daisuke, Ogura Mariko, Shinozaki Eiji, Suenaga Mitsukuni, Ozaka Masato, Wakatsuki Takeru, Ichimura Takashi, Osumi Hiroki, Yamaguchi Kensei. 腹腔細胞診陽性で肉眼的所見では腹膜転移を認めない進行性胃癌患者の治療に対するS-1+シスプラチンとS-1単剤療法の後向きによる比較検討(Retrospective comparison of S-1 plus cisplatin versus S-1 monotherapy for the treatment of advanced gastric cancer patients with positive peritoneal cytology but without gross peritoneal metastasis). International Journal of Clinical Oncology 2017.12.01

47. 小口 正彦, 室伏 景子, 田口 千藏, 吉岡 靖生, 角 美奈子, 上野 雅資, 福長 洋介, 長山 聡, 秋吉 高志, 小西 毅, 藤本 佳也, 山口 研成, 篠崎 英司, 末永 光邦, 松阪 諭. 「それぞれの癌」診断・治療の現状と展望　直腸癌　局所進行直腸癌に対する化学放射線療法. 日本癌治療学会学術集会抄録集 2017.10.01

48. Suenaga, M., Cao, S., Stintzing, S., Zhang, W., Yang, D., Ning, Y., Okazaki, S., Berger, M., Miyamoto, Y., Schirripa, M., Gopez, R., Melendez, E., Soni, S., Barzi, A., Yamaguchi, T., Heinemann, V., Lenz, H.. Genetic polymorphisms of CCL5 and CCR5 to predict efficacy of cetuximab-based treatment in metastatic colorectal cancer patients depending on primary tumor location.. 53rd ASCO annual meeting 2017.06

49. Yuji Miyamoto, Sebastian Stintzing, Volker Heinemann, Wu Zhang, Shu Cao, Satoshi Okazaki, Martin D. Berger, Mitsukuni Suenaga, Marta Schirripa, Shivani Soni, Satoshi Matsusaka, Yan Ning, Dongyun Yang, Roel Gopez, Elizabeth Melendez, Diana L. Hanna, Afsaneh Barzi, Hideo Baba, and Heinz-Josef Lenz. Association of genetic variations in genes implicated in the axis with outcome in patients (pts) with metastatic colorectal cancer (mCRC) treated with cetuximab plus chemotherapy. ASCO annual meeting 2017.06

50. Yuji Miyamoto, Fotios Loupakis, Wu Zhang, Shu Cao, Satoshi Okazaki, Martin D. Berger, Mitsukuni Suenaga, Marta Schirripa, Shivani Soni, Satoshi Matsusaka, Yan Ning, Dongyun Yang, Roel Gopez, Elizabeth Melendez, Diana L. Hanna, Afsaneh Barzi, Hideo Baba, Alfredo Falcone, and Heinz-Josef Lenz. Genetic variations in semaphorin/neuropilin signaling to predict clinical outcome in patients (pts) with metastatic colorectal cancer (mCRC) receiving bevacizumab-based chemotherapy. ASCO Annual Meeting 2017.06

51. Martin D. Berger, Sebastian Stintzing, Dongyun Yang, Shu Cao, Yuji Miyamoto, Mitsukuni Suenaga, Shivani Soni, Roel Gopez, Elizabeth Melendez, Wu Zhang, Volker Heinemann, and Heinz-Josef Lenz. Genetic variations within the vitamin C transporter genes to predict outcome in metastatic colorectal cancer patients treated with first-line FOLFIRI and bevacizumab: Data from FIRE-3 trial. ASCO Annual Meeting 2017.06

52. Suenaga, M., Cao, S., Zhang, W., Ning, Y., Okazaki, S., Berger, M., Miyamoto, Y., Schirripa, M., Gopez, R., Melendez, E., Soni, S., Barzi, A., Yamaguchi, T., Lenz, H. . Genetic variants in CCL5 and CCR5 genes and serum VEGF-A levels to predict efficacy of bevacizumab in metastatic colorectal cancer patients receiving first-line chemotherapy.. 53rd ASCO annual meeting 2017.06

53. Suenaga, M., Schirripa, M., Cao, S., Zhang, W., Yang, D., Marmorino, F., Bergamo, F., Antoniotti, C., Rossini, D., Ning, Y., Okazaki, S., Berger, M., Miyamoto, Y., Gopez, R., Hanna, D., Barzi, A., Mashima, T., Yamaguchi, T., Loupakis, F., Lenz , H.. Role of genetic polymorphisms in CCL5/CCR5 axis to predict efficacy of regorafenib in patients with refractory metastatic colorectal cancer.. ASCO Gastrointestinal Cancers Symposium 2017.01

54. Martin D. Berger, Sebastian Stintzing, Dongyun Yang, Mitsukuni Suenaga, Yuji Miyamoto, Shu Cao, Shivani Soni, Roel Gopez, Diana L. Hanna, Wu Zhang, Volker Heinemann, Heinz-Josef Lenz. Effect of polymorphisms of genes encoding regulatory proteins in the coagulation cascade on outcome for mCRC patients treated with FOLFIRI and bevacizumab: Data from FIRE-3 trial. ASCO Gastrointestinal Cancers Symposium 2017.01

55. Martin D. Berger, Sebastian Stintzing, Volker Heinemann, Dongyun Yang, Shu Cao, Yan Ning, Satoshi Okazaki, Yuji Miyamoto, Mitsukuni Suenaga, Marta Schirripa, Roel Gopez, Diana L. Hanna, Wu Zhang, Heinz-Josef Lenz. Effect of JAK2 SNP rs2274472 on outcome for mCRC patients treated with first-line FOLFIRI and bevacizumab: Data from FIRE-3 trial. ASCO Gastrointestinal Cancers Symposium 2017.01

56. Yuji Miyamoto, Sebastian Stintzing, Wu Zhang, Shu Cao, Yan Ning, Satoshi Okazaki, Martin D. Berger, Mitsukuni Suenaga, Marta Schirripa, Shivani Soni, Satoshi Matsusaka, Dongyun Yang, Roel Gopez, Diana L. Hanna, Afsaneh Barzi, Hideo Baba, Volker Heinemann, Heinz-Josef Lenz. Polymorphisms in adipokine-related genes to predict treatment outcomes in patients (pts) with metastatic colorectal cancer (mCRC) treated with bevacizumab-based chemotherapy.. ASCO Gastrointestinal Cancers Symposium 2017.01

57. Suenaga, M., Schirripa, M., Cao, S., Zhang, W., Yang, D., Salvatore, L., Lonardi, S., Moretto, R., Borelli, B., Ning, Y., Okazaki, S., Berger, M., Miyamoto, Y., Gopez, R., Hanna, D., Barz, A., Wakatsuki, T., Yamaguchi, T., Loupakis, F., Lenz, H.. Lenz, H. Genetic variants of genes in CCL5/CCR5 pathway to predict regorafenib-induced hand-foot skin reaction in patients with refractory metastatic colorectal cancer: A report of ethnic difference.. ASCO Gastrointestinal Cancers Symposium 2017.01

58. S. Okazaki, F. Loupakis, M. Schirripa, S. Cao, W. Zhang, D. Yang, Y. Ning, M. Berger, Y. Miyamoto, M. Suenaga, R. Gopez, B.B. Borelli, C. Cremolini, A. Falcone, S. Lonardi, L.Salvatore, H. Uetake, T. Kawano, T. Helentjaris, H.-J. Lenz. Tandem repeat variation in HIC1 gene predicts outcome for oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. ESMO congress 2016.10

59. Suenaga, M., Schirripa, M., Cao, S., Zhang, W., Yang, D., Berger, M., West, J., Cremolin, C., Lonardi, S., Battaglin, F., Ning, Y., Horiike, Y., Yamamoto, N., Okazaki, S., Miyamoto, Y., Hanna, D., Barzi, A., Loupakis, F., Falcone, A., Lenz, H.. Genetic variants of Pin1 to predict benefit from irinotecan and oxaliplatin based treatment in patients with metastatic colorectal cancer (mCRC).. ASCO Annual Meeting. 2016.06

60. Roel Gopez, Marta Schirripa, Wu Zhang, Shu Cao, Satoshi Okazaki, Dongyun Yang, Fotios Loupakis, Martin D. Berger, Yan Ning, Yuji Miyamoto, Mitsukuni Suenaga, Jordan David West, Diana L. Hanna, Afsaneh Barzi, Alfredo Falcone, Sebastian Stintzing, Volker Heinemann, Heinz-Josef Lenz. IRS1 and IRS2 polymorphisms and outcome in mCRC patients enrolled in the FIRE-3 trial.. ASCO Annual Meeting 2016.06